Case 290: Intravascular Cystic Synovial Sarcoma.
Adult
Contrast Media
Diagnosis, Differential
Femoral Vein
/ diagnostic imaging
Humans
Iliac Vein
/ diagnostic imaging
Iopamidol
/ analogs & derivatives
Male
Phospholipids
Pulmonary Embolism
/ diagnosis
Sarcoma, Synovial
/ diagnostic imaging
Sulfur Hexafluoride
Vascular Neoplasms
/ diagnostic imaging
Journal
Radiology
ISSN: 1527-1315
Titre abrégé: Radiology
Pays: United States
ID NLM: 0401260
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
entrez:
24
5
2021
pubmed:
25
5
2021
medline:
6
8
2021
Statut:
ppublish
Résumé
History A 26-year-old man presented with a 1-month history of chest pain, a palpable and painful right inguinal mass, and edema in the right lower extremity. One month earlier, he started to experience left chest pain with no cough. Pulmonary CT angiography (CTA) revealed a left lower lobe segmental pulmonary embolus. The local hospital made a diagnosis of pulmonary embolism. He received anticoagulants, and his chest pain was gradually relieved. At the time of current presentation, the patient was experiencing right lower extremity swelling and pain. Physical examination revealed a 4 × 3 cm palpable right inguinal mass with no redness. His medical history and family history were negative. The results of laboratory work-up were normal, with a d-dimer level of 0.16 mg/L fibrinogen equivalent units (reference range, <0.46 mg/L) and an international normalized ratio of 2.45 (therapeutic range, 2.0-3.0 for a patient taking warfarin), except the prothrombin time was 28.2 seconds (reference range, 9.6-12.8 seconds) and the activated partial thromboplastin time was 52.2 seconds (reference range, 24.8-33.8 seconds). Echocardiography, chest radiography, chest CT, and contrast-enhanced (CE) CT revealed no abnormalities. The patient underwent right lower extremity vascular conventional US (Philips IU22; Philips) with an L9-3 probe (3-9 MHz, venous condition) and contrast-enhanced US (1.5-2.0 mL, SonoVue; Bracco) with an intravenous bolus injection at the initial evaluation. Two days later, noncontrast and contrast-enhanced CT images of the lower abdomen (1.5 mL per kilogram of body weight, 300 mg/mL iomeprol, Iomeron; Bracco) were acquired for further evaluation.
Identifiants
pubmed: 34029167
doi: 10.1148/radiol.2021192863
doi:
Substances chimiques
Contrast Media
0
Phospholipids
0
contrast agent BR1
0
iomeprol
17E17JBP8L
Iopamidol
JR13W81H44
Sulfur Hexafluoride
WS7LR3I1D6
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM